Validation of the FEW16 questionnaire for the assessment of physical well‐being in patients with heart failure with reduced ejection fraction: results from the CIBIS‐ELD study

Publisher： John Wiley & Sons Inc

E-ISSN： 2055-5822|2|3|194-203

ISSN： 2055-5822

Source： ESC HEART FAILURE, Vol.2, Iss.3, 2015-09, pp. : 194-203

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Determinants of submaximal exercise capacity in patients at risk for heart failure with preserved ejection fraction—results from the DIAST‐CHF study

By  

ESC HEART FAILURE, Vol. 2, Iss. 2, 2015-06 ,pp. : 76-84

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. results from the breathing not properly multinational study

By Maisel A.S.   McCord J.   Nowak R.M.   for the Breathing Not Properly Multinational Study Investigators  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 46-46

Elsevier

Access to resources Recommend Favorite

Treatment of Heart Failure in Real‐World Clinical Practice: Findings From the REFLECT‐HF Registry in Patients With NYHA Class II Symptoms and a Reduced Ejection Fraction

By  

Clinical Cardiology, Vol. 38, Iss. 4, 2015-04 ,pp. : 200-207

John Wiley & Sons Inc

Access to resources Recommend Favorite

ESPVR, Ejection Fraction and Heart Failure

By Shoucri Rachad  

Cardiovascular Engineering: An International Journal, Vol. 10, Iss. 4, 2010-12 ,pp. : 207-212

Springer Publishing Company

Access to resources Recommend Favorite

Editorial: (New Drug (LCZ696) for the Treatment of Heart Failure with Reduced Ejection Fraction After 10 Years. Can One Study Change the Guidelines?)

By  

Current Vascular Pharmacology, Vol. 12, Iss. 6, 2014-11 ,pp. : 867-869

Bentham Science Publishers

Access to resources Recommend Favorite